Literature DB >> 26193649

Development from simple steatosis to liver cirrhosis and hepatocellular carcinoma: a 27-year follow-up case.

Tadanobu Nagaya1, Naoki Tanaka2,3, Michiharu Komatsu1, Tetsuya Ichijo1, Kenji Sano4, Akira Horiuchi5, Satoru Joshita1, Takeji Umemura1, Akihiro Matsumoto1, Kaname Yoshizawa1, Toshifumi Aoyama6, Kendo Kiyosawa7, Eiji Tanaka1.   

Abstract

Nonalcoholic fatty liver disease (NAFLD) is classified as nonalcoholic steatohepatitis (NASH) or simple steatosis (SS) according to histological findings. It is well recognized that NASH may develop into cirrhosis and hepatocellular carcinoma (HCC), both with unfavorable prognoses. Although the outlook of SS is reported to be better than that of NASH, the long-term prognosis of SS remains unclear. Here, we report the case of a patient who was diagnosed as having SS by a first liver biopsy, and later developed into cirrhosis and HCC over a period of 27 years. In 1980, a 42-year-old Japanese man was admitted because of abnormal liver function tests. He had no history of alcohol intake and was negative for hepatitis virus markers and autoantibodies. A liver biopsy specimen showed macrovesicular steatosis without ballooned hepatocytes, Mallory hyaline, lobular inflammation, or perisinusoidal/perivenular fibrosis, confirming the diagnosis of SS. The patient's serum aminotransferase levels did not normalize despite repeated dietary instruction, and in 2001, liver histology demonstrated cirrhosis with mild steatosis and hepatocyte ballooning, leading to the diagnosis of NASH-related cirrhosis. HCC appeared in 2007. Overall, this patient progressed to cirrhosis and HCC in 20 and 27 years, respectively, following initial diagnosis. Platelet counts and degree of steatosis, as assessed by periodic ultrasonography, were seen to gradually reduce with progression of fibrosis. This case demonstrates that even a diagnosis of SS does not guarantee non-progression to cirrhosis and HCC, and careful follow-up is needed not only in patients with NASH, but also in those with SS.

Entities:  

Keywords:  Hepatocellular carcinoma; Hyaluronic acid; Liver cirrhosis; Simple steatosis

Year:  2008        PMID: 26193649     DOI: 10.1007/s12328-008-0017-0

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  22 in total

1.  Laparoscopic findings in patients with nonalcoholic steatohepatitis.

Authors:  Naoki Tanaka; Tetsuya Ichijo; Wataru Okiyama; Hidetomo Mutou; Noriko Misawa; Akihiro Matsumoto; Kaname Yoshizawa; Eiji Tanaka; Kendo Kiyosawa
Journal:  Liver Int       Date:  2006-02       Impact factor: 5.828

2.  Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population.

Authors:  Naoki Tanaka; Eiji Tanaka; Yo Sheena; Michiharu Komatsu; Wataru Okiyama; Noriko Misawa; Hidetomo Muto; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Akira Horiuchi; Kendo Kiyosawa
Journal:  Liver Int       Date:  2006-10       Impact factor: 5.828

3.  Hyaluronic acid levels can predict severe fibrosis and platelet counts can predict cirrhosis in patients with nonalcoholic fatty liver disease.

Authors:  Hiroyuki Kaneda; Etsuko Hashimoto; Satoru Yatsuji; Katsutoshi Tokushige; Keiko Shiratori
Journal:  J Gastroenterol Hepatol       Date:  2006-09       Impact factor: 4.029

4.  The natural history of nonalcoholic fatty liver disease: a clinical histopathological study.

Authors:  Stephen A Harrison; Sigurd Torgerson; Paul H Hayashi
Journal:  Am J Gastroenterol       Date:  2003-09       Impact factor: 10.864

5.  Long-term follow-up of patients with NAFLD and elevated liver enzymes.

Authors:  Mattias Ekstedt; Lennart E Franzén; Ulrik L Mathiesen; Lars Thorelius; Marika Holmqvist; Göran Bodemar; Stergios Kechagias
Journal:  Hepatology       Date:  2006-10       Impact factor: 17.425

6.  Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.

Authors:  E M Brunt; C G Janney; A M Di Bisceglie; B A Neuschwander-Tetri; B R Bacon
Journal:  Am J Gastroenterol       Date:  1999-09       Impact factor: 10.864

7.  Design and validation of a histological scoring system for nonalcoholic fatty liver disease.

Authors:  David E Kleiner; Elizabeth M Brunt; Mark Van Natta; Cynthia Behling; Melissa J Contos; Oscar W Cummings; Linda D Ferrell; Yao-Chang Liu; Michael S Torbenson; Aynur Unalp-Arida; Matthew Yeh; Arthur J McCullough; Arun J Sanyal
Journal:  Hepatology       Date:  2005-06       Impact factor: 17.425

8.  The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies.

Authors:  Leon A Adams; Schuyler Sanderson; Keith D Lindor; Paul Angulo
Journal:  J Hepatol       Date:  2005-01       Impact factor: 25.083

9.  Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitis.

Authors:  Shiro Yokohama; Masashi Yoneda; Masakazu Haneda; Satoshi Okamoto; Mituyoshi Okada; Kazunobu Aso; Takenao Hasegawa; Yoshihiko Tokusashi; Naoyuki Miyokawa; Kimihide Nakamura
Journal:  Hepatology       Date:  2004-11       Impact factor: 17.425

Review 10.  Obesity, inflammation, and insulin resistance.

Authors:  Steven E Shoelson; Laura Herrero; Afia Naaz
Journal:  Gastroenterology       Date:  2007-05       Impact factor: 22.682

View more
  10 in total

1.  Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy.

Authors:  Naoki Tanaka; Akira Horiuchi; Takahide Yokoyama; Gengo Kaneko; Naoto Horigome; Takahiro Yamaura; Tadanobu Nagaya; Michiharu Komatsu; Kenji Sano; Shin-Ichi Miyagawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2011-01-26       Impact factor: 7.527

2.  Relationship between Liver Stiffness and Steatosis in Obesity Conditions: In Vivo and In Vitro Studies.

Authors:  Francesca Baldini; Mohamad Khalil; Alice Bartolozzi; Massimo Vassalli; Agostino Di Ciaula; Piero Portincasa; Laura Vergani
Journal:  Biomolecules       Date:  2022-05-23

3.  Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits.

Authors:  Goro Tsuruta; Naoki Tanaka; Minoru Hongo; Michiharu Komatsu; Akira Horiuchi; Kaeko Hamamoto; Chieko Iguchi; Yoshiko Nakayama; Takeji Umemura; Tetsuya Ichijo; Akihiro Matsumoto; Kaname Yoshizawa; Toshifumi Aoyama; Eiji Tanaka
Journal:  J Gastroenterol       Date:  2010-01-19       Impact factor: 7.527

4.  Pancreatic fat accumulation, fibrosis, and acinar cell injury in the Zucker diabetic fatty rat fed a chronic high-fat diet.

Authors:  Akiko Matsuda; Naohiko Makino; Tomohiro Tozawa; Nakao Shirahata; Teiichiro Honda; Yushi Ikeda; Hideyuki Sato; Miho Ito; Yasuharu Kakizaki; Manabu Akamatsu; Yoshiyuki Ueno; Sumio Kawata
Journal:  Pancreas       Date:  2014-07       Impact factor: 3.327

5.  Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease.

Authors:  Naoyuki Fujimori; Takeji Umemura; Takefumi Kimura; Naoki Tanaka; Ayumi Sugiura; Tomoo Yamazaki; Satoru Joshita; Michiharu Komatsu; Yoko Usami; Kenji Sano; Koji Igarashi; Akihiro Matsumoto; Eiji Tanaka
Journal:  World J Gastroenterol       Date:  2018-03-21       Impact factor: 5.742

6.  Association between endotoxemia and histological features of nonalcoholic fatty liver disease.

Authors:  Hiroyuki Kitabatake; Naoki Tanaka; Naoyuki Fujimori; Michiharu Komatsu; Ayaka Okubo; Kyogo Kakegawa; Takefumi Kimura; Ayumi Sugiura; Tomoo Yamazaki; Soichiro Shibata; Yuki Ichikawa; Satoru Joshita; Takeji Umemura; Akihiro Matsumoto; Masayoshi Koinuma; Kenji Sano; Toshifumi Aoyama; Eiji Tanaka
Journal:  World J Gastroenterol       Date:  2017-01-28       Impact factor: 5.742

7.  Modeling the natural history of fatty liver using lifestyle-related risk factors: Effects of body mass index (BMI) on the life-course of fatty liver.

Authors:  Mika Aizawa; Seiichi Inagaki; Michiko Moriyama; Kenichiro Asano; Masayuki Kakehashi
Journal:  PLoS One       Date:  2019-10-21       Impact factor: 3.240

8.  Impact of qualitative endoscopic ultrasonography on fatty pancreas at a referral medical center.

Authors:  Atsushi Kawamura; Kazuki Takakura; Yuichi Torisu; Yuji Kinoshita; Yoichi Tomita; Masanori Nakano; Takashi Yamauchi; Machi Suka; Kazuki Sumiyama; Shigeo Koido; Masayuki Saruta
Journal:  JGH Open       Date:  2021-12-12

9.  The Nutraceutic Silybin Counteracts Excess Lipid Accumulation and Ongoing Oxidative Stress in an In Vitro Model of Non-Alcoholic Fatty Liver Disease Progression.

Authors:  Giulia Vecchione; Elena Grasselli; Federica Cioffi; Francesca Baldini; Paulo J Oliveira; Vilma A Sardão; Katia Cortese; Antonia Lanni; Adriana Voci; Piero Portincasa; Laura Vergani
Journal:  Front Nutr       Date:  2017-09-19

Review 10.  PPARs as Metabolic Regulators in the Liver: Lessons from Liver-Specific PPAR-Null Mice.

Authors:  Yaping Wang; Takero Nakajima; Frank J Gonzalez; Naoki Tanaka
Journal:  Int J Mol Sci       Date:  2020-03-17       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.